Dr Ed Day MA BM BCh DM MRCPsych

Dr Ed Day

School of Psychology
Clinical Reader in Addiction Psychiatry
Institute for Mental Health

Dr Ed Day is a Psychiatrist who combines clinical work in the NHS with research and teaching. He specializes in the treatment of drug and alcohol use disorders, and his research focuses on testing novel pharmacological and psychosocial interventions. He was appointed the National Recovery Champion by the Home Office in May 2019.

Learn more

Qualifications

MA, BM, BCh, DM, MRCPsych

Teaching

Ed set up and ran an MSC program in the Treatment of Addictive Behaviours at the University of Birmingham between 2008 and 2012. He currently teaches about addictions-related issues on the DClinPsy, MBChB, and MPharm courses, and is developing a module on addictions and mental illness on the new Institute for Mental Health MSc program.

Postgraduate supervision

Addictions
Treatment of alcohol or drug use disorders

Other activities

Executive member of the Society for the Study of Addiction (SSA) 2007-present, and currently the Vice-President.

Elected member of the Addictions Faculty at the Royal College of Psychiatry in 2018, and former Vice-Chair and Academic Secretary.

Appointed by the Home Office as the National Drug Recovery Champion in May 2019

Publications

Recent publications

Article

Pang, D, Duffield, P & Day, E 2019, 'A view from the acute hospital: managing patients with alcohol problems', British journal of hospital medicine, vol. 80, no. 9, pp. 500-506. https://doi.org/10.12968/hmed.2019.80.9.500

Day, E, Kirberg, S & Metrebian, N 2019, 'Affiliation to Alcoholics Anonymous or Narcotics Anonymous among patients attending an English specialist addiction service', Drugs and Alcohol Today, vol. 19, no. 4, pp. 257-269. https://doi.org/10.1108/DAT-05-2019-0017

Kuningas, K, Driscoll, J, Mair, R, Smith, H, Dutton, M, Day, E & Sharif, A 2019, 'Comparing glycaemic benefits of active versus passive lifestyle intervention in kidney allograft recipients (CAVIAR): a randomised controlled trial', Transplantation. https://doi.org/10.1097/TP.0000000000002969

Strang, J, Kelleher, M, Mayet, S, Day, E, Hellier, J, Byford, S, Murphy, C, McLennan, B, Shearer, J, Ryan, E & Marsden, J 2019, 'Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT', Health Technology Assessment, vol. 23, no. 3, pp. 1-71. https://doi.org/10.3310/hta23030

Goranitis, I, Coast, J, Day, E, Copello, A, Freemantle, N, Seddon, J, Bennett, C & Frew, E 2019, 'Measuring health and broader wellbeing benefits in the context of opiate dependence: the psychometric performance of ICECAP-A and EQ-5D-5L: Using ICECAP-A and EQ-5D-5L in drug addiction', Value in Health, vol. 19, no. 6, pp. 820-828. https://doi.org/10.1016/j.jval.2016.04.010

Emmerson, O, London, K, Akhtar, S, Lowe, E & Day, E 2018, ''You should be helping him, he's trying to do something about it': the dilemma of heroin use, agonist opioid treatment and employment', Heroin Addiction and Related Clinical Problems, vol. 20, no. 6, pp. 17-25.

Day, E, Copello, A, Seddon, J, Christie, M, Bamber, D, Powell, C, Bennett, C, Akhtar, S, George, S, Ball, A, Frew, E, Goranitis, I & Freemantle, N 2018, 'A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services', BMC Psychiatry, vol. 18, no. 8, 8. https://doi.org/10.1186/s12888-018-1600-7

Bogdanowicz, KM, Stewart, R, Chang, C-K, Shetty, H, Khondoker, M, Day, E, Hayes, RD & Strang, J 2018, 'Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy', Addiction, vol. 113, no. 5, pp. 946-951. https://doi.org/10.1111/add.14114

Anderson, B, Dutton, M, Day, E, Jackson, T, Ferro, CJ & Sharif, A 2018, 'Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial', Trials, vol. 19, no. 1, 457. https://doi.org/10.1186/s13063-018-2842-x, https://doi.org/10.1186/s13063-018-2842-x

Metrebian, N, Weaver, T, Pilling, S, Hellier, J, Byford, S, Shearer, JD, Mitcheson, L, Astbury, M, Bijral, P, Bogdan, N, Bowden-Jones, O, Day, E, Dunn, J, Finch, E, Forshall, S, Glasper, A, Morse, G, Akhtar, S, Bajaria, J, Bennett, C, Bishop, E, Charles, V, Davey, C, Desai, R, Goodfellow, C, Haque, F, Little, N, McKechnie, H, Morris, J, Mosler, F, Mutz, J, Pauli, R, Poovendran, D, Slater, E & Strang, J 2018, 'Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management', Contemporary Clinical Trials, vol. 71, pp. 124-132. https://doi.org/10.1016/j.cct.2018.06.008

Peak, J, Goranitis, I, Day, E, Copello, A, Freemantle, N & Frew, E 2018, 'Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP', Health and Quality Life Outcomes, vol. 16, 106. https://doi.org/10.1186/s12955-018-0926-7

Lowe, E, Akhtar, S, Emmerson, O, Parkman, T & Day, E 2018, 'The impact of employment on perceived recovery from opiate dependence', Drugs and Alcohol Today, vol. 18, no. 4, pp. 206-216. https://doi.org/10.1108/DAT-12-2017-0062

Kalk, NJ, Robertson, JR, Kidd, B, Day, E, Kelleher, MJ, Gilvarry, E & Strang, J 2018, 'Treatment and intervention for opiate dependence in the United Kingdom: lessons from triumph and failure', European Journal on Criminal Policy and Research, vol. 24, no. 2, pp. 183–200. https://doi.org/10.1007/s10610-017-9364-z

Comment/debate

Day, E 2018, 'Commentary on Jones et al. (2018): an inconvenient truth-complex problems require complex solutions', Addiction, vol. 113, no. 2, pp. 287-288. https://doi.org/10.1111/add.14070

Review article

Day, E & Rudd, J 2019, 'Alcohol use disorders and the heart', Addiction, vol. 114, no. 9, pp. 1670-1678. https://doi.org/10.1111/add.14703

View all publications in research portal